Precigen
NASDAQ: PGENGermantown, US · Virginia corporation · 2 known investors
Precigen is a biopharmaceutical company developing precision medicines for immuno-oncology, autoimmune disorders, and infectious diseases with high unmet patient need.
Founders & leadership
TR
Thomas R. KasserExecutive Officer
DJ
Dean J. MitchellDirector
TD
Thomas D. ReedExecutive Officer
RB
Robert B. ShapiroDirector
CL
Cesar L. AlvarezDirector
SM
Suma M. KrishnanExecutive Officer
JB
Jeffrey B. KindlerDirector
DP
Donald P. LehrExecutive Officer
SF
Steven FrankDirector
JS
James S. TurleyDirector
LD
Larry D. HornerDirector
RF
Robert F. Walsh, IIIExecutive Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$13MraisedDec 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$13MraisedDec 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rick L. SterlingExecutive Officer
- Donald P. LehrExecutive Officer
- Jeffrey PerezExecutive Officer
- Helen Sabzevari, Ph.D.Executive Officer, Director
- Randal J. KirkDirector
- Cesar L. AlvarezDirector
- James S. TurleyDirector
- Vinita D. GuptaDirector
- Fred HassanDirector
- Jeffrey B. KindlerDirector
- Dean J. MitchellDirector
- Robert B. ShapiroDirector
- Steven FrankDirector
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- Dec 2020
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$35MraisedFeb 2020 · 1 investors · BiotechnologyRule 506(b)
▶$35MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James S. TurleyDirector
- Robert B. ShapiroDirector
- Dean J. MitchellDirector
- Jeffrey B. KindlerDirector
- Fred HassanDirector
- Vinita D. GuptaDirector
- Steven FrankDirector
- Cesar L. AlvarezDirector
- Randal KirkDirector, Executive Officer
- Helen Sabzevari, Ph.D.Executive Officer
- Jeffrey PerezExecutive Officer
- Thomas Reed, Ph.D.Executive Officer
- Rick L. SterlingExecutive Officer
- Donald P. LehrExecutive Officer
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Jan 2020
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$4.3MraisedMar 2016 · 2 investors · BiotechnologyRule 506(b)
▶$4.3MraisedMar 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James S. TurleyDirector
- Samuel BroderExecutive Officer
- Jeffrey B. KindlerDirector
- Thomas D. ReedExecutive Officer
- Robert F. Walsh, IIIExecutive Officer
- Joseph L. VaillancourtExecutive Officer
- Rick L. SterlingExecutive Officer
- Cesar L. AlvarezDirector
- Steven FrankDirector
- Randal J. KirkExecutive Officer, Director
- Dean J. MitchellDirector
- Suma M. KrishnanExecutive Officer
- Ena Chan CratsenburgExecutive Officer
- Nir NimrodiExecutive Officer
- Joel D. LiffmannExecutive Officer
- Krish S. KrishnanExecutive Officer
- Robert B. ShapiroDirector
- Corey HuckExecutive Officer
- Jeffrey T. PerezExecutive Officer
- Donald P. LehrExecutive Officer
- Jack A. BoboExecutive Officer
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- First sale
- Feb 2016
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$21.6MraisedSep 2015 · 20 investors · BiotechnologyRule 506(b)
▶$21.6MraisedSep 2015 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry D. HornerDirector
- Dean J. MitchellDirector
- Olivier R. JarryExecutive Officer
- Donald P. LehrExecutive Officer
- Cesar L. AlvarezDirector
- Rick L. SterlingExecutive Officer
- Randal J. KirkExecutive Officer, Director
- James S. TurleyDirector
- Thomas D. ReedExecutive Officer
- Jeffrey T. PerezExecutive Officer
- Steven FrankDirector
- Krish S. KrishnanExecutive Officer
- Robert F. Walsh, IIIExecutive Officer
- Robert B. ShapiroDirector
- Joel D. LiffmanExecutive Officer
- Jeffrey L. KindlerDirector
- Jack A. BoboExecutive Officer
- Nir NimrodiExecutive Officer
- Suma M. KrishnanExecutive Officer
- Samuel BroderExecutive Officer
- Offering amount
- $21.6M
- Amount sold
- $21.6M
- First sale
- Sep 2015
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$450KraisedMar 2015 · 1 investors · BiotechnologyRule 506(b)
▶$450KraisedMar 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Krish S. KrishnanExecutive Officer
- Thomas R. KasserExecutive Officer
- Suma M. KrishnanExecutive Officer
- Donald P. LehrExecutive Officer
- Dean J. MitchellDirector
- Rick L. SterlingExecutive Officer
- Robert F. Walsh, IIIExecutive Officer
- Gregory I. FrostExecutive Officer
- James S. TurleyDirector
- Jeffrey T. PerezExecutive Officer
- Darryl WebsterExecutive Officer
- Thomas D. ReedExecutive Officer
- Steven FrankDirector
- Larry D. HornerDirector
- Randal J. KirkExecutive Officer, Director
- Robert B. ShapiroDirector
- Jeffrey B. KindlerDirector
- Cesar L. AlvarezDirector
- Nir NimrodiExecutive Officer
- Offering amount
- $450K
- Amount sold
- $450K
- First sale
- Feb 2015
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$10.2MraisedMar 2015 · 78 investors · BiotechnologyRule 506(b)
▶$10.2MraisedMar 2015 · 78 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert F. Walsh, IIIExecutive Officer
- Robert B. ShapiroDirector
- Suma M. KrishnanExecutive Officer
- Jeffrey T. PerezExecutive Officer
- Gregory I. FrostExecutive Officer
- Donald P. LehrExecutive Officer
- Krish S. KrishnanExecutive Officer
- Thomas D. ReedExecutive Officer
- Jeffrey B. KindlerDirector
- Thomas R. KasserExecutive Officer
- Randal J. KirkExecutive Officer, Director
- James S. TurleyDirector
- Dean J. MitchellDirector
- Rick L. SterlingExecutive Officer
- Darryl WebsterExecutive Officer
- Nir NimrodiExecutive Officer
- Larry D. HornerDirector
- Steven FrankDirector
- Cesar L. AlvarezDirector
- Offering amount
- $10.2M
- Amount sold
- $10.2M
- First sale
- Feb 2015
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$57.5MraisedJan 2015 · 1 investors · BiotechnologyRule 506(b)
▶$57.5MraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas R. KasserExecutive Officer
- Dean J. MitchellDirector
- Thomas D. ReedExecutive Officer
- Robert B. ShapiroDirector
- Cesar L. AlvarezDirector
- Suma M. KrishnanExecutive Officer
- Jeffrey B. KindlerDirector
- Donald P. LehrExecutive Officer
- Steven FrankDirector
- James S. TurleyDirector
- Larry D. HornerDirector
- Robert F. Walsh, IIIExecutive Officer
- Rick L. SterlingExecutive Officer
- Randal J. KirkExecutive Officer, Director
- Krish S. KrishnanExecutive Officer
- Darryl WebsterExecutive Officer
- Gregory I. FrostExecutive Officer
- Nir NimrodiExecutive Officer
- Offering amount
- $57.5M
- Amount sold
- $57.5M
- First sale
- Jan 2015
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 1
Early investors' stakes continue via these dealsOxitec
Flyttr operates a biosecurity platform that develops and deploys countermeasures against pest threats, combining autonomous pest monitoring systems, AI-powered decision-support, and biological interventions such as engineered Aedes aegypti and Wolbachia. It serves national governments, agricultural authorities, industry partners and field operators across public health, agriculture, and livestock domains.